HydroBiome introduces DtpA, a novel bacterial hydrophilin technology, to enhance probiotic stability and efficacy. This innovation protects probiotics from desiccation, heat, and oxidative stress, improving shelf stability and reducing CFU loss during manufacturing and storage.
HydroBiome's innovative DtpA hydrophilin technology aims to revolutionize the probiotic industry by significantly enhancing the stability and efficacy of probiotic strains. This technology modifies probiotics to withstand desiccation, heat, and oxidative stress, ensuring higher colony-forming unit (CFU) counts throughout the supply chain. By improving the survivability of probiotics, DtpA provides a more reliable and effective product for consumers, extending shelf life and maintaining potency during manufacturing, shipping, and storage.
Key features:
Applications:
This technology is currently at TRL 4, with successful proof of concept demonstrated in E.coli Nissle. Future validations include engineering and testing DtpA-expressing Lactobacillus and Bifidobacterium strains, assessing compatibility with gummy manufacturing, and evaluating long-term viability and shelf stability.